Marker Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.87

-0.03 (-3.33%)

As of Nov 14, 10:56 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,770.1% upside

Low Target $12.16

Average Target $16.27

High Target $21.27

Current Price $0.87

Current
$0.87

Target
$16.27

$12.16 $16.27 avg $21.27

Scenario Analysis

Bear Case

$12.16

1,297.7%

Low target

Base Case

$16.27

+1,770.1%

Avg target

Bull Case

$21.27

+2,344.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.46

-64.6% from high

52-Week Low

$0.87

+0.0% from low

Target vs 52W High

$16.27

+561.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%